KvarQ

KvarQ performs rapid in silico genotyping of bacterial genome sequences by scanning raw FastQ reads for predefined single nucleotide polymorphisms (SNPs) and short genomic regions to detect variants and phylogenetic or drug-resistance markers without mapping reads to a reference or performing de novo assembly.

Key Features:

• Direct Variant Detection: Scans FastQ files to identify known genetic variants, including single nucleotide polymorphisms (SNPs) and short regions of interest, without read mapping or assembly.
• Testsuite Framework: Utilizes predefined "testsuites," which are sets of SNPs or genomic markers tailored to targeted analyses of particular organisms.
• Reference-based Marker Definitions: Testsuites define specific SNPs or genomic regions of interest within a reference genome.
• Customizable Testsuites: Includes testsuites for Mycobacterium tuberculosis and supports creation and distribution of new testsuites for other organisms.

Scientific Applications:

• Targeted Genotyping: Enables targeted genotyping directly from raw FastQ data for bacterial genomes.
• Drug Resistance Detection: Detects major drug resistance mutations in bacterial genomes.
• Phylogenetic Marker Identification: Identifies phylogenetic markers for strain typing and evolutionary analyses.
• Validation and Benchmarking: In a validation study of 880 whole genome sequences, KvarQ achieved over 99% congruency with standard bioinformatics pipelines.

Methodology:

KvarQ loads testsuites that define specific SNPs or genomic regions within a reference genome, directly scans FastQ files for those markers, synthesizes results based on marker presence or absence, and reports results (average scan time reported as ~2 minutes per genome).